Cargando…
Comparison of different anticoagulation strategies for renal replacement therapy in critically ill patients with COVID-19: a cohort study
BACKGROUND: Critically ill coronavirus disease 2019 (COVID-19) patients have a high risk of acute kidney injury (AKI) that requires renal replacement therapy (RRT). A state of hypercoagulability reduces circuit life spans. To maintain circuit patency and therapeutic efficiency, an optimized anticoag...
Autores principales: | Arnold, Frederic, Westermann, Lukas, Rieg, Siegbert, Neumann-Haefelin, Elke, Biever, Paul Marc, Walz, Gerd, Kalbhenn, Johannes, Tanriver, Yakup |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7668013/ https://www.ncbi.nlm.nih.gov/pubmed/33198670 http://dx.doi.org/10.1186/s12882-020-02150-8 |
Ejemplares similares
-
Integration of sustained low‐efficiency dialysis into extracorporeal membrane oxygenation circuit in critically ill COVID‐19 patients—A feasibility study
por: Arnold, Frederic, et al.
Publicado: (2022) -
Subcutaneous Enoxaparin Safely Facilitates Bedside Sustained Low-Efficiency Hemodialysis in Hypercoagulopathic Coronavirus Disease 2019 Patients—A Proof-of-Principle Trial
por: Neumann-Haefelin, Elke, et al.
Publicado: (2020) -
Antibiotic Stewardship (ABS) im Kontext schwerer Infektionen
por: Giesen, Roland, et al.
Publicado: (2022) -
Therapy with lopinavir/ritonavir and hydroxychloroquine is associated with acute kidney injury in COVID-19 patients
por: Schneider, Johanna, et al.
Publicado: (2021) -
Treating C3 glomerulopathy with eculizumab
por: Welte, Thomas, et al.
Publicado: (2018)